The Australian Diabetes Society has issued an alert on the risks of diabetic ketoacidosis (DKA) in people taking SGLT2 inhibitors during the peri-operative period. The alert follows reports of patients with type 2 diabetes developing severe acidosis with the drugs during the peri-operative period, particular if they had been fasting or were dehydrated. Unusually, DKA ...
Type 2 diabetes
7 practice points for peri-operative SGLT2 inhibitor use
By Michael Woodhead
28 Feb 2018